Address	99 Mount Street North Sydney New South Wales (NSW) 2060 Australia
Employees	-
Website	http://www.benitec.com
Updated	07/08/2019
Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene silencing technology called ddRNAi. It develops treatments for chronic and life threatening human conditions, such as oculopharyngeal muscular dystrophy, oncology, wet age-related macular degeneration, and hepatitis B. It operates through the Australia and USA geographical segments.